TriNetX is a federated clinical data network of providers, pharmaceutical companies and contract research organizations (CROs) used to enhance clinical trial design and accelerate trial site and patient recruitment. TriNetX membership increases the flow of sponsored research to providers and enables pharmaceutical companies to find the right patients at the right sites for clinical trials.
The TriNetX Network can facilitate participation in new industry-sponsored clinical trials while improving the design and subject accrual for clinical studies. TriNetX also supports deeper insights into a patient cohort to enhance your investigators’ research programs, and enables them to collaborate with peers and other member institutions.
Access to more Clinical Trials – Fund your research with sponsorship from pharmaceutical companies.
Exploratory Research – Better understand the target patient population to aid in development of a study protocol.
Patient Recruitment – Identify patients that meet study eligibility criteria.
Create Peer Networks – Collaborate with other TriNetX members nationally.
NIH Funding Acknowledgment:Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.